{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:12Z","timestamp":1792785012166,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Taishan Young Scholar Program","award":["tsqn202211351"],"award-info":[{"award-number":["tsqn202211351"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79791-4","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T03:09:27Z","timestamp":1732504167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mendelian randomization analysis reveals causal effects of inflammatory bowel disease and autoimmune hyperthyroidism on diffuse large B-cell lymphoma risk"],"prefix":"10.1038","volume":"14","author":[{"given":"Chunyi","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"79791_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"79791_CR2","doi-asserted-by":"publisher","unstructured":"Susanibar-Adaniya, S. & Barta, S. K. Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management. Am. J. Hematol. 96, 617\u2013629. https:\/\/doi.org\/10.1002\/ajh.26151 (2021).","DOI":"10.1002\/ajh.26151"},{"key":"79791_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3892\/ol.2017.7538","volume":"15","author":"YW Xu","year":"2017","unstructured":"Xu, Y. W. & Duan, M. H. A unique bone marrow lymphoma patient presenting with an isolated mass: a case report. Oncol. Lett. 15, 2529\u20132533. https:\/\/doi.org\/10.3892\/ol.2017.7538 (2017).","journal-title":"Oncol. Lett."},{"key":"79791_CR4","doi-asserted-by":"publisher","first-page":"102945","DOI":"10.1016\/j.critrevonc.2020.102945","volume":"150","author":"S Khanmohammadi","year":"2020","unstructured":"Khanmohammadi, S., Shabani, M., Tabary, M., Rayzan, E. & Rezaei, N. Lymphoma in the setting of autoimmune diseases: a review of association and mechanisms. Crit. Rev. Oncol. Hematol. 150, 102945. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102945 (2020).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"79791_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","volume":"24","author":"E Baecklund","year":"2014","unstructured":"Baecklund, E., Smedby, K. E., Sutton, L. A., Askling, J. & Rosenquist, R. Lymphoma development in patients with autoimmune and inflammatory disorders\u2013what are the driving forces? Semin Cancer Biol. 24, 61\u201370. https:\/\/doi.org\/10.1016\/j.semcancer.2013.12.001 (2014).","journal-title":"Semin Cancer Biol."},{"key":"79791_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/10428190902780677","volume":"50","author":"DN Martin","year":"2009","unstructured":"Martin, D. N., Mikhail, I. S. & Landgren, O. Autoimmunity and hematologic malignancies: associations and mechanisms. Leuk. Lymphoma. 50, 541\u2013550. https:\/\/doi.org\/10.1080\/10428190902780677 (2009).","journal-title":"Leuk. Lymphoma"},{"key":"79791_CR7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood.2019003686","volume":"139","author":"E Porpaczy","year":"2022","unstructured":"Porpaczy, E. & J\u00e4ger, U. How I manage autoimmune cytopenias in patients with lymphoid cancer. Blood 139, 1479\u20131488. https:\/\/doi.org\/10.1182\/blood.2019003686 (2022).","journal-title":"Blood"},{"key":"79791_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1158\/1055-9965.EPI-06-0786","volume":"16","author":"P Boffetta","year":"2007","unstructured":"Boffetta, P. et al. Consortia in Cancer Epidemiology: lessons from InterLymph. Cancer Epidemiol. Biomarkers Prev. 16, 197\u2013199. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0786 (2007).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"79791_CR9","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"KE Smedby","year":"2008","unstructured":"Smedby, K. E. et al. Autoimmune disorders and risk of non-hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111, 4029\u20134038. https:\/\/doi.org\/10.1182\/blood-2007-10-119974 (2008).","journal-title":"Blood"},{"key":"79791_CR10","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N. & Smith, G. D. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163. https:\/\/doi.org\/10.1002\/sim.3034 (2008).","journal-title":"Stat. Med."},{"key":"79791_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/0962280206077743","volume":"16","author":"V Didelez","year":"2016","unstructured":"Didelez, V. & Sheehan, N. Mendelian randomization as an instrumental variable approach to causal inference. Stat. Methods Med. Res. 16, 309\u2013330. https:\/\/doi.org\/10.1177\/0962280206077743 (2016).","journal-title":"Stat. Methods Med. Res."},{"key":"79791_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s42003-021-02227-6","volume":"4","author":"K Valette","year":"2021","unstructured":"Valette, K. et al. Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank. Commun. Biology. 4, 700. https:\/\/doi.org\/10.1038\/s42003-021-02227-6 (2021).","journal-title":"Commun. Biology"},{"key":"79791_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518. https:\/\/doi.org\/10.1038\/s41586-022-05473-8 (2023).","journal-title":"Nature"},{"key":"79791_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979\u2013986. https:\/\/doi.org\/10.1038\/ng.3359 (2015).","journal-title":"Nat. Genet."},{"key":"79791_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","volume":"47","author":"S Onengut-Gumuscu","year":"2015","unstructured":"Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381\u2013386. https:\/\/doi.org\/10.1038\/ng.3245 (2015).","journal-title":"Nat. Genet."},{"key":"79791_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","volume":"45","author":"(IMSGC)","year":"2013","unstructured":"(IMSGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353\u20131360. https:\/\/doi.org\/10.1038\/ng.2770 (2013).","journal-title":"Nat. Genet."},{"key":"79791_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"IGASIG o","year":"2013","unstructured":"o., I. G. A. S. I. G. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45, 730\u2013738. https:\/\/doi.org\/10.1038\/ng.2667 (2013).","journal-title":"Nat. Genet."},{"key":"79791_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.998","volume":"43","author":"G Trynka","year":"2011","unstructured":"Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193\u20131201. https:\/\/doi.org\/10.1038\/ng.998 (2011).","journal-title":"Nat. Genet."},{"key":"79791_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA 326, 1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236 (2021).","journal-title":"JAMA"},{"key":"79791_CR20","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin, C. A., Khera, A. V. & Kathiresan, S. Mendelian Randomization JAMA 318, 1925\u20131926, doi:https:\/\/doi.org\/10.1001\/jama.2017.17219 (2017).","journal-title":"Mendelian Randomization JAMA"},{"key":"79791_CR21","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Smith, G. D. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362, k601. https:\/\/doi.org\/10.1136\/bmj.k601 (2018).","journal-title":"BMJ"},{"key":"79791_CR22","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat, M. A. et al. PhenoScanner V2: an expanded tool for searching human genotype\u2013phenotype associations. Bioinformatics 35, 4851\u20134853. https:\/\/doi.org\/10.1093\/bioinformatics\/btz469 (2019).","journal-title":"Bioinformatics"},{"key":"79791_CR23","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce, B. L. & Burgess, S. Efficient design for mendelian randomization studies: Subsample and 2-Sample instrumental variable estimators. Am. J. Epidemiol. 178, 1177\u20131184. https:\/\/doi.org\/10.1093\/aje\/kwt084 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"79791_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fgene.2020.00824","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Serum calcium levels and Parkinson\u2019s Disease: a mendelian randomization study. Front. Genet. 11, 824. https:\/\/doi.org\/10.3389\/fgene.2020.00824 (2020).","journal-title":"Front. Genet."},{"key":"79791_CR25","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien, T. W. & Tedder, T. F. B lymphocytes: how they develop and function. Blood 112, 1570\u20131580. https:\/\/doi.org\/10.1182\/blood-2008-02-078071 (2008).","journal-title":"Blood"},{"key":"79791_CR26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/ijc.24141","volume":"124","author":"LR Goldin","year":"2009","unstructured":"Goldin, L. R. & Landgren, O. Autoimmunity and lymphomagenesis. Int. J. Cancer. 124, 1497\u20131502. https:\/\/doi.org\/10.1002\/ijc.24141 (2009).","journal-title":"Int. J. Cancer"},{"key":"79791_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cppeds.2014.10.003","volume":"44","author":"A Kaistha","year":"2014","unstructured":"Kaistha, A. & Levine, J. Inflammatory bowel disease: the classic gastrointestinal autoimmune disease. Curr. Probl. Pediatr. Adolesc. Health Care. 44, 328\u2013334. https:\/\/doi.org\/10.1016\/j.cppeds.2014.10.003 (2014).","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"79791_CR28","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1053\/gast.2001.29271","volume":"121","author":"WJ Sandborn","year":"2001","unstructured":"Sandborn, W. J. Lymphoma risk in inflammatory bowel disease: influences of referral bias and therapy. Gastroenterology 121, 1239\u20131242. https:\/\/doi.org\/10.1053\/gast.2001.29271 (2001).","journal-title":"Gastroenterology"},{"key":"79791_CR29","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10620-010-1430-z","volume":"56","author":"MV Chiorean","year":"2010","unstructured":"Chiorean, M. V. et al. Incidence and risk factors for lymphoma in a single-center inflammatory bowel disease population. Dig. Dis. Sci. 56, 1489\u20131495. https:\/\/doi.org\/10.1007\/s10620-010-1430-z (2010).","journal-title":"Dig. Dis. Sci."},{"key":"79791_CR30","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1053\/gast.2001.28703","volume":"121","author":"JD Lewis","year":"2001","unstructured":"Lewis, J. D. et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121, 1080\u20131087. https:\/\/doi.org\/10.1053\/gast.2001.28703 (2001).","journal-title":"Gastroenterology"},{"key":"79791_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/gut.2004.051771","volume":"54","author":"J Askling","year":"2005","unstructured":"Askling, J. et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54, 617\u2013622. https:\/\/doi.org\/10.1136\/gut.2004.051771 (2005).","journal-title":"Gut"},{"key":"79791_CR32","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1016\/j.cgh.2023.04.001","volume":"21","author":"O Ol\u00e9n","year":"2023","unstructured":"Ol\u00e9n, O. et al. Increasing risk of Lymphoma over Time in Crohn\u2019s Disease but not in Ulcerative Colitis: a scandinavian cohort study. Clin. Gastroenterol. Hepatol. 21, 3132\u20133142. https:\/\/doi.org\/10.1016\/j.cgh.2023.04.001 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"79791_CR33","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","volume":"91","author":"CN Bernstein","year":"2001","unstructured":"Bernstein, C. N., Blanchard, J. F., Kliewer, E. & Wajda, A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91, 854\u2013862 (2001).","journal-title":"Cancer"},{"key":"79791_CR34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/ecco-jcc\/jjab164","volume":"16","author":"F Phillips","year":"2022","unstructured":"Phillips, F. et al. Diagnosis and outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: an ECCO CONFER Case Series. J. Crohns Colitis. 16, 500\u2013505. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab164 (2022).","journal-title":"J. Crohns Colitis"},{"key":"79791_CR35","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1097\/MIB.0b013e318281325e","volume":"19","author":"W Afif","year":"2013","unstructured":"Afif, W. et al. Risk factors for Lymphoma in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 19, 1384\u20131389. https:\/\/doi.org\/10.1097\/MIB.0b013e318281325e (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"79791_CR36","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/ajg.2011.479","volume":"107","author":"M Bewtra","year":"2012","unstructured":"Bewtra, M. Lymphoma in inflammatory bowel disease and treatment decisions. Am. J. Gastroenterol. 107, 964\u2013970. https:\/\/doi.org\/10.1038\/ajg.2011.479 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"79791_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/ecco-jcc\/jjz204","volume":"14","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T., Uda, A., Udagawa, E. & Hibi, T. Lack of increased risk of Lymphoma by thiopurines or biologics in Japanese patients with inflammatory bowel disease: a large-Scale Administrative Database Analysis. J. Crohns Colitis. 14, 617\u2013623. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz204 (2020).","journal-title":"J. Crohns Colitis"},{"key":"79791_CR38","doi-asserted-by":"publisher","first-page":"622648","DOI":"10.3389\/fonc.2021.622648","volume":"11","author":"P Li","year":"2021","unstructured":"Li, P. et al. Genomic mutation Profile of primary gastrointestinal diffuse large B-Cell lymphoma. Front. Oncol. 11, 622648. https:\/\/doi.org\/10.3389\/fonc.2021.622648 (2021).","journal-title":"Front. Oncol."},{"key":"79791_CR39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1089\/thy.2004.14.772","volume":"14","author":"Y Doi","year":"2004","unstructured":"Doi, Y. et al. Primary thyroid lymphoma associated with Graves\u2019 disease. Thyroid 14, 772\u2013776. https:\/\/doi.org\/10.1089\/thy.2004.14.772 (2004).","journal-title":"Thyroid"},{"key":"79791_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/blood.V21.3.282.282","volume":"21","author":"JE Ultmann","year":"1963","unstructured":"Ultmann, J. E., Hyman, G. A. & Calder, B. The occurrence of lymphoma in patients with long-standing hyperthyroidism. Blood 21, 282\u2013297. https:\/\/doi.org\/10.1182\/blood.V21.3.282.282 (1963).","journal-title":"Blood"},{"key":"79791_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/20009666.2020.1829403","volume":"11","author":"T Lanham","year":"2021","unstructured":"Lanham, T., Lanham, E., Sullivan, A. & Magaji, V. Non-hodgkin lymphoma of the thyroid in a patient with hyperthyroidism. J. Community Hosp. Intern. Med. Perspect. 11, 79\u201380. https:\/\/doi.org\/10.1080\/20009666.2020.1829403 (2021).","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"79791_CR42","doi-asserted-by":"publisher","first-page":"4354595","DOI":"10.1155\/2022\/4354595","volume":"2022","author":"M Al-Mansour","year":"2022","unstructured":"Al-Mansour, M. et al. The risk of developing lymphoma among autoimmune thyroid disorder patients: a cross-section study. Dis. Markers. 2022, 4354595. https:\/\/doi.org\/10.1155\/2022\/4354595 (2022).","journal-title":"Dis. Markers"},{"key":"79791_CR43","doi-asserted-by":"publisher","first-page":"e34885","DOI":"10.7759\/cureus.34885","volume":"15","author":"MW Sharif","year":"2023","unstructured":"Sharif, M. W., Mungara, S., Bajaj, K. & Amador, P. Khandelwal, N. Orbital Lymphoma Masquerading as Euthyroid Orbitopathy. Cureus 15, e34885. https:\/\/doi.org\/10.7759\/cureus.34885 (2023).","journal-title":"Cureus"},{"key":"79791_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-009-0019-x","volume":"97","author":"A Abdullah","year":"2009","unstructured":"Abdullah, A., Elsamaloty, H., Patel, Y. & Chang, J. CT and MRI findings with histopathologic correlation of a unique bilateral orbital mantle cell lymphoma in Graves\u2019 disease: a case report and brief review of literature. J. Neurooncol. 97, 279\u2013284. https:\/\/doi.org\/10.1007\/s11060-009-0019-x (2009).","journal-title":"J. Neurooncol."},{"key":"79791_CR45","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.eye.6702027","volume":"20","author":"CM Nutting","year":"2005","unstructured":"Nutting, C. M., Shah-Desai, S., Rose, G. E., Norton, A. P. & Plowman, P. N. Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma. Eye 20, 645\u2013648. https:\/\/doi.org\/10.1038\/sj.eye.6702027 (2005).","journal-title":"Eye"},{"key":"79791_CR46","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1210\/jcem.84.4.5642","volume":"84","author":"R Wozniak","year":"1999","unstructured":"Wozniak, R., Beckwith, L., Ratech, H. & Surks, M. I. Maltoma of the thyroid in a man with Hashimoto\u2019s thyroiditis. J. Clin. Endocrinol. Metab. 84, 1206\u20131209. https:\/\/doi.org\/10.1210\/jcem.84.4.5642 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"79791_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2133.1987.tb05820.x","volume":"116","author":"RB Mallett","year":"1987","unstructured":"Mallett, R. B., Langtry, J. A., Harper, J. I. & Staughton, R. C. Psoriasis, razoxane and a cutaneous B-cell lymphoma. Br. J. Dermatol. 116, 243\u2013244. https:\/\/doi.org\/10.1111\/j.1365-2133.1987.tb05820.x (1987).","journal-title":"Br. J. Dermatol."},{"key":"79791_CR48","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/sj.jid.5700410","volume":"126","author":"JM Gelfand","year":"2006","unstructured":"Gelfand, J. M. et al. The risk of Lymphoma in patients with psoriasis. J. Invest. Dermatol.. 126, 2194\u20132201. https:\/\/doi.org\/10.1038\/sj.jid.5700410 (2006).","journal-title":"J. Invest. Dermatol."},{"key":"79791_CR49","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/bjd.16245","volume":"178","author":"MR Kamstrup","year":"2018","unstructured":"Kamstrup, M. R., Skov, L., Zachariae, C., Thyssen, J. P. & Egeberg, A. Psoriasis and risk of malignant lymphoma: a population-based cohort study. Br. J. Dermatol. 178, 1435\u20131436. https:\/\/doi.org\/10.1111\/bjd.16245 (2018).","journal-title":"Br. J. Dermatol."},{"key":"79791_CR50","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah, M. et al. Autoimmune diseases associated with non-hodgkin lymphoma: a nationwide cohort study. Ann. Oncol. 25, 2025\u20132030. https:\/\/doi.org\/10.1093\/annonc\/mdu365 (2014).","journal-title":"Ann. Oncol."},{"key":"79791_CR51","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.287.11.1413","volume":"287","author":"C Catassi","year":"2002","unstructured":"Catassi, C. et al. Risk of Non-hodgkin Lymphoma in Celiac Disease. JAMA 287, 1413\u20131419. https:\/\/doi.org\/10.1001\/jama.287.11.1413 (2002).","journal-title":"JAMA"},{"key":"79791_CR52","doi-asserted-by":"publisher","unstructured":"Mart\u00edn-Masot, R. et al. Celiac Disease is a risk factor for mature T and NK Cell Lymphoma: a mendelian randomization study. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24087216 (2023).","DOI":"10.3390\/ijms24087216"},{"key":"79791_CR53","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10067-008-0925-x","volume":"27","author":"E Szekanecz","year":"2008","unstructured":"Szekanecz, E. et al. Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis. Clin. Rheumatol. 27, 1163\u20131166. https:\/\/doi.org\/10.1007\/s10067-008-0925-x (2008).","journal-title":"Clin. Rheumatol."},{"key":"79791_CR54","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1212\/nxi.0000000000000227","volume":"3","author":"S Montgomery","year":"2016","unstructured":"Montgomery, S. et al. Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma. Neurol. Neuroimmunol. Neuroinflammation. 3, e227. https:\/\/doi.org\/10.1212\/nxi.0000000000000227 (2016).","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"79791_CR55","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00296-009-1265-0","volume":"31","author":"K Aksu","year":"2009","unstructured":"Aksu, K., Cagirgan, S., Ozsan, N., Keser, G. & Sahin, F. Non-hodgkin\u2019s lymphoma following treatment with etanercept in ankylosing spondylitis. Rheumatol. Int. 31, 1645\u20131647. https:\/\/doi.org\/10.1007\/s00296-009-1265-0 (2009).","journal-title":"Rheumatol. Int."},{"key":"79791_CR56","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1136\/ard.2005.047514","volume":"65","author":"J Askling","year":"2006","unstructured":"Askling, J., Klareskog, L., Blomqvist, P., Fored, M. & Feltelius, N. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann. Rheum. Dis. 65, 1184\u20131187. https:\/\/doi.org\/10.1136\/ard.2005.047514 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"79791_CR57","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/art.38339","volume":"66","author":"H K","year":"2014","unstructured":"K, H. et al. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Arthritis Rheumatol. 66, 1282\u20131290. https:\/\/doi.org\/10.1002\/art.38339 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"79791_CR58","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/qjmed\/hcv039","volume":"108","author":"\u00c9 Chalayer","year":"2015","unstructured":"Chalayer, \u00c9. et al. Sarcoidosis and lymphoma: a comparative study. QJM: Mon. J. Assoc. Phys.. 108, 871\u2013878. https:\/\/doi.org\/10.1093\/qjmed\/hcv039 (2015).","journal-title":"QJM: Mon. J. Assoc. Phys."},{"key":"79791_CR59","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1183\/09031936.00043010","volume":"36","author":"IC Papanikolaou","year":"2010","unstructured":"Papanikolaou, I. C. & Sharma, O. P. The relationship between sarcoidosis and lymphoma. Eur. Respir. J. 36, 1207\u20131219. https:\/\/doi.org\/10.1183\/09031936.00043010 (2010).","journal-title":"Eur. Respir. J."},{"key":"79791_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.diabet.2019.04.006","volume":"46","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Association between type 1 and type 2 diabetes and risk of non-hodgkin\u2019s lymphoma: a meta-analysis of cohort studies. Diabetes Metab. 46, 8\u201319. https:\/\/doi.org\/10.1016\/j.diabet.2019.04.006 (2020).","journal-title":"Diabetes Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79791-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T04:02:27Z","timestamp":1732507347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79791-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79791"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79791-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29163"}}